Coronary Stents Market 2018-2026 | Size, Share and Forecast | Credence Research

The global coronary stents market was valued at US$ 6,216.7 Mn in 2017, and is expected to reach US$ 11,622.5 Mn by 2026, expanding at a CAGR of 7.3% from 2018 to 2026.

The latest market report published by Credence Research, Inc. "Global Coronary Stents Market -Growth, Future Prospects, Competitive Analysis, 2018 -2026," the global coronary stents market was valued at US$ 6,216.7 million in 2017 and is expected to reach US$ 11,622.5 million by 2026, expanding at a CAGR of 7.3% from 2018 to 2026.

By Product: Drug Eluting Stent, Bare Metal Stent, Bioresorbable Vascular Scaffolds

Coronary artery disease develops in patients when the heart is damaged by the coronary artery that delivers blood, nutrients, and oxygen. The plaque-containing cholesterol is deposited in the coronary artery over a period of time resulting in inflammation. Repeated inflammation of the vascular cell wall coupled with atherosclerotic plaque deposition causes the formation of neointima hyperplasia at the site of vessel damage.

Don't miss out on business opportunities in Coronary Stents Market

The coronary artery eventually narrows, which creates tremendous pressure on the heart, eventually resulting in myocardial infarction or stroke. At the blockade site, coronary stents are used to widen the artery. Technological advancement has been made in the manufacturing of stents over the past two decades to counteract complications such as restenosis and stent-in-stent procedure. The only limitation faced by the coronary stents market is the exorbitant price of drug-eluting stents and competition from percutaneous coronary intervention. Drug-eluting stents currently dominate the coronary stents market due to key factors such as increased prevalence of coronary artery stenosis, technological advancement in the formulation of biodegradable polymers containing antiproliferative agents to prevent restenosis.

Drug-eluting stents are completely overshadowing the bare metal stents due to the inherent qualities it possesses such as surface smoothness, thinner struts, and durable metal alloys. Bioresorbable vascular scaffolds are gaining prominence in the treatment of coronary artery diseases due to key factors such as the ability to restore normal vessel shape and function, eliminate vessel irritation and inflammation, and excellent patient compliance.

North America dominates the regional coronary stents market segment in the current scenario. According to the statistics presented annually by the Center for Disease Control and Prevention (CDC), 370,000 U.S. citizens die from coronary artery disease. Because of their unhealthy lifestyle, tobacco smoking, and increased obesity, the American Africans are at a higher risk for cardiovascular disease.

Market growth in Europe is determined by the presence of key players such as Abbott Laboratories, Inc. and Medtronic, Plc. Pioneering in the manufacturing of coronary stents. The Asia Pacific is set to register significant growth during the forecast period owing to the rising prevalence of cardiovascular ailment, the rise in per capita income and growth in medical tourism.

The major players engaged in the manufacturing of coronary stents are Amaranth Medical, Inc., Abbott Laboratories, Inc., Boston Scientific Corporation, Cook Medical, Inc., B. Braun Melsungen AG, C.R. Bard, Inc., Biotronik SE & Co. KG, Medtronic Plc, Terumo Corporation and Microport Scientific Corporation.

Key Market Movements:

Rising prevalence of cardiovascular complications and obesity in developed nations
Growing public health awareness regarding heart ailments and adherence to effective treatment guidelines to drive market growth in developing nations
Technological advancement in stent development to minimize restenosis and improve patient compliance
Get Sample(Free) @

Chapter 1. Preface
Chapter 2. Executive Summary
Chapter 3. Coronary Stents Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Coronary Stents Market, by Key Players, 2017

Chapter 4. Global Coronary Stents Market, by Product
4.1. Overview
4.2. Drug Eluting Stent
4.3. Bare Metal Stent
4.4. Bioresorbable Vascular Scaffolds

Chapter 5. Global Coronary Stents Market, by Geography
Chapter 6. Company Profiles
6.1. Abbott Laboratories, Inc.
6.1.1. Business Description
6.1.2. Financial Information (Subject to data availability)
6.1.3. Product Portfolio
6.1.4. News Coverage
6.2. Amaranth Medical, Inc.
6.3. Biotronik SE & Co. KG
6.4. B.Braun Melsungen AG
6.5. Boston Scientific Corporation
6.6. Cook Medical, Inc.
6.7. C.R. Bard, Inc.
6.8. Johnson & Johnson
6.9. Medtronic, Plc
6.10. Microport Scientific Corporation
6.11. Terumo Corporation
..................................toc continued

Browse the full report Coronary Stents Market - Growth, Future Prospects, Competitive Analysis, 2018 – 2026 report at

About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.

Contact Info:
Name: Chris Smith
Email: Send Email
Organization: Credence Research
Address: 105 N 1st ST #429, SAN JOSE,, CA 95103, United States
Phone: 18003618290

Release ID: 496791